We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
American Express
AXP
$227B
| $109M | 0.25% |
1,372,966
+33,577
| +3% | +$2.63M |
|
77
ConocoPhillips
COP
$142B
| $109M | 0.25% |
2,176,127
+63,893
| +3% | +$3.09M |
|
78
American International
AIG
$42.8B
| $106M | 0.25% |
1,695,889
+8,310
| +0.5% | +$534K |
|
79
Simon Property Group
SPG
$76.6B
| $106M | 0.25% |
614,914
+32,465
| +6% | +$5.8M |
|
80
Morgan Stanley
MS
$329B
| $105M | 0.25% |
2,453,787
+68,161
| +3% | +$3.02M |
|
81
Adobe
ADBE
$99.2B
| $105M | 0.24% |
803,844
+12,883
| +2% | +$1.51M |
|
82
PNC Financial Services
PNC
$100B
| $102M | 0.24% |
848,681
+21,414
| +3% | +$2.62M |
|
83
Duke Energy
DUK
$103B
| $100M | 0.23% |
1,221,694
+42,013
| +4% | +$3.34M |
|
84
Netflix
NFLX
$306B
| $99.1M | 0.23% |
6,707,850
+76,530
| +1% | +$1.07M |
|
85
American Tower
AMT
$82B
| $97M | 0.23% |
797,798
+37,633
| +5% | +$4.14M |
|
86
EOG Resources
EOG
$75.9B
| $96.6M | 0.23% |
990,278
+31,939
| +3% | +$3.19M |
|
87
TJX Companies
TJX
$178B
| $93.8M | 0.22% |
2,373,108
+33,240
| +1% | +$1.28M |
|
88
Kraft Heinz
KHC
$32.7B
| $93.4M | 0.22% |
1,028,548
+23,750
| +2% | +$2.14M |
|
89
Thermo Fisher Scientific
TMO
$217B
| $92.7M | 0.22% |
603,270
-13,306
| -2% | -$2.03M |
|
90
Biogen
BIIB
$30.1B
| $92.6M | 0.22% |
338,632
-29,033
| -8% | -$8.21M |
|
91
MetLife
MET
$62.3B
| $89.9M | 0.21% |
1,908,759
+59,881
| +3% | +$2.85M |
|
92
Danaher
DHR
$146B
| $89.2M | 0.21% |
1,175,770
+36,340
| +3% | +$2.7M |
|
93
Blackrock
BLK
$167B
| $88.4M | 0.21% |
230,601
+5,651
| +3% | +$2.16M |
|
94
Occidental Petroleum
OXY
$54.9B
| $86.4M | 0.2% |
1,362,856
+41,177
| +3% | +$2.74M |
|
95
Kimberly-Clark
KMB
$38B
| $86.2M | 0.2% |
654,914
+14,452
| +2% | +$1.82M |
|
|
RAI
96
DELISTED
Reynolds American Inc
RAI
| $84.9M | 0.2% |
1,347,782
+27,458
| +2% | +$1.65M |
|
|
MON
97
DELISTED
Monsanto Co
MON
| $84.5M | 0.2% |
746,743
+13,419
| +2% | +$1.49M |
|
98
Southern Company
SO
$111B
| $84.5M | 0.2% |
1,697,698
+52,493
| +3% | +$2.59M |
|
99
Caterpillar
CAT
$382B
| $84.2M | 0.2% |
907,958
+10,853
| +1% | +$1.03M |
|
100
Automatic Data Processing
ADP
$106B
| $83.8M | 0.2% |
818,067
+10,082
| +1% | +$1.03M |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.